Legal Representation
Attorney
Maury M. Tepper, III
USPTO Deadlines
Application History
37 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 9, 2018 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 8, 2018 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Sep 5, 2018 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Sep 5, 2018 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Mar 2, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 28, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 28, 2018 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Feb 28, 2018 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Aug 18, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 16, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 16, 2017 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Aug 16, 2017 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Feb 2, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 2, 2017 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Feb 2, 2017 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jan 31, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 31, 2017 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jan 31, 2017 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Aug 26, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 24, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 24, 2016 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Aug 24, 2016 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 1, 2016 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 5, 2016 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 5, 2016 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 16, 2015 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 19, 2015 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 18, 2015 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 18, 2015 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 18, 2015 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 18, 2015 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 18, 2015 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 18, 2015 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 15, 2015 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 26, 2015 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Feb 25, 2015 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 13, 2015 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of diabetes, obesity and metabolic diseases and disorders; drug delivery systems comprised of an implantable pump filled with pharmaceutical preparations for use in treating diabetes, obesity and metabolic diseases/disorders
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
Drug delivery systems, namely an implantable pump; medical apparatus for the administration of pharmaceuticals in the nature of an implantable pump; medical apparatus for treatment of diabetes, obesity and metabolic diseases/disorders in the nature of an incretin memetic pump
First Use Anywhere:
0
First Use in Commerce:
0
Class 041
Development and dissemination of printed and electronic educational materials of others in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies and administration of pharmaceuticals; educational services, namely, conducting classes, seminars, conferences, workshops, field trips and programs in the fields of diabetes, obesity, metabolic diseases/disorders, and treatments relating thereto, drug delivery technologies and administration of pharmaceuticals, and distribution of educational material in connection therewith
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Research and development of pharmaceutical preparations, products and technology in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals for others; medical and scientific research in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals; providing medical and scientific research information in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, administration of pharmaceuticals, pharmaceuticals, and clinical trials; scientific investigations for medical purposes; medical research; design and testing of new products, technologies and therapies in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals for others; providing information in the fields of clinical trials of pharmaceuticals
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Medical information services, namely, providing information on the topics of diabetes, obesity, and metabolic diseases/disorders and the diagnosis, treatment and management therapies relating thereto; providing information in the fields of medicine, pharmaceuticals, drug delivery technologies, and administration of pharmaceuticals
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of capitalized three-dimensional letters "T2D" connected by a cylinder horizontally going through the middle of each letter.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
T TWO D; T TO D
Classification
International Classes
005
010
041
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"T2D"